Protagonist Therapeutics, Inc (PTGX) — Analysis Summary
Protagonist Therapeutics, Inc (PTGX) has a market cap of $7.23B with year-over-year revenue growth of -89.4%. Net margin stands at -282.8%. The stock trades at a P/E ratio of -63.0.
Key Takeaways
- Revenue changed -89.4% year-over-year
- Net margin of -282.8%
- P/E ratio of -63.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, PTGX posted revenue growth of -89.4% and trades at a P/E of -63.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.